
|Articles|December 1, 2007
Senators ponder ethical conflicts of doctor-drug company relationships
Congress has been warned that many doctors are "on the take" from big pharmaceutical companies, which pay them in one way or another to prescribe their drugs to patients, and are "at risk of corruption" while endangering the lives of patients.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Issues Warnings to Websites Illegally Marketing Botox and Related Products
2
Heather C. Woolery-Lloyd, MD, FAAD, Explores the Latest Cosmeceuticals at SDPA Fall 2025
3
The Science of Sensitive Skin: Evidence-Based Cleansing and Moisturizing Practices for Protecting and Repairing the Skin Barrier: Part 1
4
Cutaneous Clues to Systemic Disease: A Rheumatology Overview for Dermatologists
5




















